Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury

Abstract Background Traumatic spinal cord injury (SCI) includes the primary insult as well as a sequela of biochemical and cellular cascades that amplifies the initial injury. This degenerative process, known as secondary injury, is often mediated by both reactive oxygen and nitrogen species release...

Full description

Bibliographic Details
Main Authors: Wen Gao, Jianming Li
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12951-017-0272-7
id doaj-ceddd59dc30b42f88025fe7b3f4d3337
record_format Article
spelling doaj-ceddd59dc30b42f88025fe7b3f4d33372020-11-24T20:55:15ZengBMCJournal of Nanobiotechnology1477-31552017-05-0115111110.1186/s12951-017-0272-7Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injuryWen Gao0Jianming Li1Department of Basic Medical Sciences, Center for Paralysis Research, College of Veterinary Medicine, Purdue UniversityDepartment of Basic Medical Sciences, Center for Paralysis Research, College of Veterinary Medicine, Purdue UniversityAbstract Background Traumatic spinal cord injury (SCI) includes the primary insult as well as a sequela of biochemical and cellular cascades that amplifies the initial injury. This degenerative process, known as secondary injury, is often mediated by both reactive oxygen and nitrogen species released from damaged cells. Previous data suggests that dysregulated production of nitric oxide via inducible nitric oxide synthase (iNOS) is detrimental to spinal cord recovery. M1 macrophages have been implicated to overexpress iNOS post-SCI. In this work, we propose to inhibit iNOS expression through small interfering RNA (siRNA) complexed chitosan nanoparticles (NPs) that primarily target M1 macrophages. Methods siRNA conjugated chitosan complexes were fabricated with and without an antibody (Ab) targeting moiety and screened for efficiency to reduce iNOS expression in vitro. Best formulations were subsequently applied in vivo following acute SCI in a rodent model. iNOS expression as well as Bax and Bcl-2 biomarkers were used to assess cell apoptosis within the lesion at 24 h post-injury. Results Ab-siRNA conjugated chitosan NPs significantly reduced iNOS expression in vitro in M1 polarized macrophages. Results show high transfection efficiency with low cytotoxicity. Subsequent application of NPs in vivo after SCI demonstrated both a reduction in iNOS expression and cellular apoptosis. Conclusion Proof of concept indicates that siRNA conjugated chitosan NPs can downregulate iNOS production and inhibit apoptosis following SCI. Our proposed gene silencing method putatively targets M1 macrophages as a means to attenuate secondary injury.http://link.springer.com/article/10.1186/s12951-017-0272-7siRNAChitosan nanoparticlesSpinal cord injuryM1 macrophageiNOSApoptosis
collection DOAJ
language English
format Article
sources DOAJ
author Wen Gao
Jianming Li
spellingShingle Wen Gao
Jianming Li
Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury
Journal of Nanobiotechnology
siRNA
Chitosan nanoparticles
Spinal cord injury
M1 macrophage
iNOS
Apoptosis
author_facet Wen Gao
Jianming Li
author_sort Wen Gao
title Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury
title_short Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury
title_full Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury
title_fullStr Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury
title_full_unstemmed Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury
title_sort targeted sirna delivery reduces nitric oxide mediated cell death after spinal cord injury
publisher BMC
series Journal of Nanobiotechnology
issn 1477-3155
publishDate 2017-05-01
description Abstract Background Traumatic spinal cord injury (SCI) includes the primary insult as well as a sequela of biochemical and cellular cascades that amplifies the initial injury. This degenerative process, known as secondary injury, is often mediated by both reactive oxygen and nitrogen species released from damaged cells. Previous data suggests that dysregulated production of nitric oxide via inducible nitric oxide synthase (iNOS) is detrimental to spinal cord recovery. M1 macrophages have been implicated to overexpress iNOS post-SCI. In this work, we propose to inhibit iNOS expression through small interfering RNA (siRNA) complexed chitosan nanoparticles (NPs) that primarily target M1 macrophages. Methods siRNA conjugated chitosan complexes were fabricated with and without an antibody (Ab) targeting moiety and screened for efficiency to reduce iNOS expression in vitro. Best formulations were subsequently applied in vivo following acute SCI in a rodent model. iNOS expression as well as Bax and Bcl-2 biomarkers were used to assess cell apoptosis within the lesion at 24 h post-injury. Results Ab-siRNA conjugated chitosan NPs significantly reduced iNOS expression in vitro in M1 polarized macrophages. Results show high transfection efficiency with low cytotoxicity. Subsequent application of NPs in vivo after SCI demonstrated both a reduction in iNOS expression and cellular apoptosis. Conclusion Proof of concept indicates that siRNA conjugated chitosan NPs can downregulate iNOS production and inhibit apoptosis following SCI. Our proposed gene silencing method putatively targets M1 macrophages as a means to attenuate secondary injury.
topic siRNA
Chitosan nanoparticles
Spinal cord injury
M1 macrophage
iNOS
Apoptosis
url http://link.springer.com/article/10.1186/s12951-017-0272-7
work_keys_str_mv AT wengao targetedsirnadeliveryreducesnitricoxidemediatedcelldeathafterspinalcordinjury
AT jianmingli targetedsirnadeliveryreducesnitricoxidemediatedcelldeathafterspinalcordinjury
_version_ 1716791981301039104